Ex Vivo Platforms


Champions Oncology’s Ex Vivo platforms not only can be used to gather additional in vivo model data throughout the in-life portion of your studies as well as at study completion, they also can address mechanisms of action for immuno-oncology agents and test for cytotoxicity of oncology therapeutics in an ex vivo system. 

Using multiplex cytokine assays with flow cytometry readouts, immune cell cytokine intracellular and extracellular staining upon activation can be assessed. Champions Oncology can also collect tissues from your in vivo studies and evaluate pathological changes throughout the tissue and/or the tumor itself using Immunohistochemistry (IHC) and bioanalytical chemistry (i.e. Luminex/ELISA platforms).